Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
Published in: Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 1/2016

Open Access 01-12-2016 | Original research

Elevations in growth hormone and glucagon-like peptide-2 levels on admission are associated with increased mortality in trauma patients

Authors: Matthew P. Rowan, Darrick J. Beckman, Julie A. Rizzo, Claire L. Isbell, Christopher E. White, Stephen M. Cohn, Kevin K. Chung

Published in: Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine | Issue 1/2016

Login to get access

Abstract

Background

Burn and trauma patients present a clinical challenge due to metabolic derangements and hypermetabolism that result in a prolonged catabolic state with impaired healing and secondary complications, including ventilator dependence. Previous work has shown that circulating levels of growth hormone (GH) are predictive of mortality in critically ill adults, but few studies have examined the prognostic potential of GH levels in adult trauma patients.

Methods

To investigate the utility of GH and other endocrine responses in the prediction of outcomes, we conducted a prospective, observational study of adult burn and trauma patients. We evaluated the serum concentration of GH, insulin-like growth factor 1 (IGF-1), IGF binding protein 3 (IGFBP-3), and glucagon-like peptide-2 (GLP-2) weekly for up to 6 weeks in 36 adult burn and trauma patients admitted between 2010 and 2013.

Results

Non-survivors had significantly higher levels of GH and GLP-2 on admission than survivors.

Discussion

This study demonstrates that GH has potential as a predictor of mortality in critically ill trauma and burn patients. Future studies will focus on not only the role of GH, but also GLP-2, which was shown to correlate with mortality in this study with a goal of offering early, targeted therapeutic interventions aimed at decreasing mortality in the critically injured.

Conclusions

GH and GLP-2 may have clinical utility for outcome prediction in adult trauma patients.
Appendix
Available only for authorised users
Literature
1.
Preiser JC, Ichai C, Orban JC, Groeneveld AJ. Metabolic response to the stress of critical illness. Br J Anaesth. 2014;113(6):945–54.PubMedCrossRef
2.
Arnold J, Campbell IT, Samuels TA, Devlin JC, Green CJ, Hipkin LJ, MacDonald IA, Scrimgeour CM, Smith K, Rennie MJ. Increased whole body protein breakdown predominates over increased whole body protein synthesis in multiple organ failure. Clin Sci (Lond). 1993;84(6):655–61.CrossRef
3.
Dempsey DT, Mullen JL, Buzby GP. The link between nutritional status and clinical outcome: can nutritional intervention modify it? Am J Clin Nutr. 1988;47(2 Suppl):352–6.PubMed
4.
Rennie MJ. Muscle protein turnover and the wasting due to injury and disease. Br Med Bull. 1985;41(3):257–64.PubMed
5.
Taylor BE, Buchman TG. Is there a role for growth hormone therapy in refractory critical illness? Curr Opin Crit Care. 2008;14(4):438–44.PubMedCrossRef
6.
Lang CH, Frost RA. Role of growth hormone, insulin-like growth factor-I, and insulin-like growth factor binding proteins in the catabolic response to injury and infection. Curr Opin Clin Nutr Metab Care. 2002;5(3):271–9.PubMedCrossRef
7.
8.
Baxter RC. The insulin-like growth factor (IGF)-IGF-binding protein axis in critical illness. Growth Horm IGF Res. 1999;9 Suppl A:67–9.PubMedCrossRef
9.
Gielen M, Mesotten D, Brugts M, Coopmans W, Van Herck E, Vanhorebeek I, Baxter R, Lamberts S, Janssen JA, Van den Berghe G. Effect of intensive insulin therapy on the somatotropic axis of critically ill children. J Clin Endocrinol Metab. 2011;96(8):2558–66.PubMedCrossRef
10.
11.
Mesotten D, Van den Berghe G. Changes within the GH/IGF-I/IGFBP axis in critical illness. Crit Care Clin. 2006;22(1):17–28. v.PubMedCrossRef
12.
Gianotti L, Stella M, Bollero D, Broglio F, Lanfranco F, Aimaretti G, Destefanis S, Casati M, Magliacani G, Ghigo E. Activity of GH/IGF-1 axis in burn patients: comparison with normal subjects and patients with GH deficiency. J Endocrinol Invest. 2002;25(2):116–24.PubMedCrossRef
13.
Jeffries MK, Vance ML. Growth hormone and cortisol secretion in patients with burn injury. J Burn Care Rehabil. 1992;13(4):391–5.PubMedCrossRef
14.
Plank LD, Hill GL. Sequential metabolic changes following induction of systemic inflammatory response in patients with severe sepsis or major blunt trauma. World J Surg. 2000;24(6):630–8.PubMedCrossRef
15.
Bondy CA, Underwood LE, Clemmons DR, Guler HP, Bach MA, Skarulis M. Clinical uses of insulin-like growth factor I. Ann Intern Med. 1994;120(7):593–601.PubMedCrossRef
16.
Huang KF, Chung DH, Herndon DN. Insulinlike growth factor 1 (IGF-1) reduces gut atrophy and bacterial translocation after severe burn injury. Arch Surg. 1993;128(1):47–53. discussion −4.PubMedCrossRef
17.
Steenfos HH. Growth factors and wound healing. Scand J Plast Reconstr Surg Hand Surg. 1994;28(2):95–105.PubMedCrossRef
18.
Strock LL, Singh H, Abdullah A, Miller JA, Herndon DN. The effect of insulin-like growth factor I on postburn hypermetabolism. Surgery. 1990;108(2):161–4.PubMed
19.
Belcher HJ, Mercer D, Judkins KC, Shalaby S, Wise S, Marks V, Tanner NS. Biosynthetic human growth hormone in burned patients: a pilot study. Burns. 1989;15(2):99–107.PubMedCrossRef
20.
Herndon DN, Barrow RE, Kunkel KR, Broemeling L, Rutan RL. Effects of recombinant human growth hormone on donor-site healing in severely burned children. Ann Surg. 1990;212(4):424–9. discussion 30–1.PubMedPubMedCentralCrossRef
21.
Jiang H, Sun MW, Hefright B, Chen W, Lu CD, Zeng J. Efficacy of hypocaloric parenteral nutrition for surgical patients: a systematic review and meta-analysis. Clin Nutr. 2011;30(6):730–7.PubMedCrossRef
22.
Ward HC, Halliday D, Sim AJ. Protein and energy metabolism with biosynthetic human growth hormone after gastrointestinal surgery. Ann Surg. 1987;206(1):56–61.PubMedPubMedCentralCrossRef
23.
Douglas RG, Humberstone DA, Haystead A, Shaw JH. Metabolic effects of recombinant human growth hormone: isotopic studies in the postabsorptive state and during total parenteral nutrition. Br J Surg. 1990;77(7):785–90.PubMedCrossRef
24.
Knox J, Demling R, Wilmore D, Sarraf P, Santos A. Increased survival after major thermal injury: the effect of growth hormone therapy in adults. J Trauma. 1995;39(3):526–30. discussion 30–2.PubMedCrossRef
25.
Losada F, Garcia-Luna PP, Gomez-Cia T, Garrido M, Pereira JL, Marin F, Astorga R. Effects of human recombinant growth hormone on donor-site healing in burned adults. World J Surg. 2002;26(1):2–8.PubMedCrossRef
26.
Mlcak RP, Suman OE, Murphy K, Herndon DN. Effects of growth hormone on anthropometric measurements and cardiac function in children with thermal injury. Burns. 2005;31(1):60–6.PubMedCrossRef
27.
Przkora R, Herndon DN, Suman OE, Jeschke MG, Meyer WJ, Chinkes DL, Mlcak RP, Huang T, Barrow RE. Beneficial effects of extended growth hormone treatment after hospital discharge in pediatric burn patients. Ann Surg. 2006;243(6):796–801. discussion −3.PubMedPubMedCentralCrossRef
28.
29.
Singh KP, Prasad R, Chari PS, Dash RJ. Effect of growth hormone therapy in burn patients on conservative treatment. Burns. 1998;24(8):733–8.PubMedCrossRef
30.
Suman OE, Thomas SJ, Wilkins JP, Mlcak RP, Herndon DN. Effect of exogenous growth hormone and exercise on lean mass and muscle function in children with burns. J Appl Physiol (1985). 2003;94(6):2273–81.CrossRef
31.
Breederveld RS, Tuinebreijer WE. Recombinant human growth hormone for treating burns and donor sites. Cochrane Database Syst Rev. 2014;9:CD008990.PubMed
32.
Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinckx G, Hinds CJ. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med. 1999;341(11):785–92.PubMedCrossRef
33.
Kyle UG, Jolliet P, Genton L, Meier CA, Mensi N, Graf JD, Chevrolet JC, Pichard C. Clinical evaluation of hormonal stress state in medical ICU patients: a prospective blinded observational study. Intensive Care Med. 2005;31(12):1669–75.PubMedCrossRef
34.
Sharshar T, Bastuji-Garin S, Polito A, De Jonghe B, Stevens RD, Maxime V, Rodriguez P, Cerf C, Outin H, Touraine P, Laborde K. Hormonal status in protracted critical illness and in-hospital mortality. Crit Care. 2011;15:R47.PubMedPubMedCentralCrossRef
35.
Schuetz P, Muller B, Nusbaumer C, Wieland M, Christ-Crain M. Circulating levels of GH predict mortality and complement prognostic scores in critically ill medical patients. Eur J Endocrinol. 2009;160(2):157–63.PubMedCrossRef
36.
Diaz EC, Herndon DN, Porter C, Sidossis LS, Suman OE, Borsheim E. Effects of pharmacological interventions on muscle protein synthesis and breakdown in recovery from burns. Burns. 2015;41(4):649–57.PubMedCrossRef
37.
Jeschke MG, Finnerty CC, Kulp GA, Przkora R, Micak RP, Herndon DN. Combinaton of recombinant human growth hormone and propranolol decreases hypermetabolism and inflammation in severely burned children. Pediatr Crit Care Med. 2008;9(2):209–16.PubMedCrossRef
38.
Ho KY, Weissberger AJ. The antinatriuretic action of biosynthetic human growth hormone in man involves activation of the renin-angiotensin system. Metabolism. 1990;39(2):133–7.PubMedCrossRef
39.
Knox JB, Demling RH, Wilmore DW, Sarraf P, Santos AA. Hypercalcemia associated with the use of human growth hormone in an adult surgical intensive care unit. Arch Surg. 1995;130(4):442–5.PubMedCrossRef
Metadata
Title
Elevations in growth hormone and glucagon-like peptide-2 levels on admission are associated with increased mortality in trauma patients
Authors
Matthew P. Rowan
Darrick J. Beckman
Julie A. Rizzo
Claire L. Isbell
Christopher E. White
Stephen M. Cohn
Kevin K. Chung
Publication date
01-12-2016
Publisher
BioMed Central
DOI
https://doi.org/10.1186/s13049-016-0310-8

Other articles of this Issue 1/2016

Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 1/2016 Go to the issue

Original research

An epidemiological approach to mass casualty incidents in the Principality of Asturias (Spain)

Original research

Short structured feedback training is equivalent to a mechanical feedback device in two-rescuer BLS: a randomised simulation study

Original research

Occupational stress experienced by residents and faculty physicians on night shifts

Review

Accidental hypothermia–an update

Original research

Cardiopulmonary responses during the cooling and the extracorporeal life support rewarming phases in a porcine model of accidental deep hypothermic cardiac arrest

Original research

Routine whole body CT of high energy trauma patients leads to excessive radiation exposure